In Cytomegalovirus Infection Cytomegalovirus infection is a common virus infection which may have no symptoms at all or may have symptoms like fever and fatigue. Severe infection may show symptoms involving the eyes, brain, or other internal organs. This virus is spread through sexual and nonsexual contact with body secretions in people who are immunocompromised or those who have undergone any transplant. Gavir 250 Capsule helps to prevent multiplication of the infection causing virus and treats the infection. Keep taking it in the dose and duration prescribed by the doctor to get maximum benefit.
It is not known whether it is safe to consume alcohol with Gavir 250 Capsule. Please consult your doctor.
Gavir 250 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Gavir 250 Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Gavir 250 Capsule may cause side effects which could affect your ability to drive. You may feel sleepy, dizzy, confused or shaky, or you may lose your balance or have fits while using Gavir 250 Capsule.
Gavir 250 Capsule should be used with caution in patients with kidney disease. Dose adjustment of Gavir 250 Capsule may be needed. Please consult your doctor. Regular monitoring of kidney function test and some blood tests may be advised while you are taking this medicine.
Gavir 250 Capsule should be used with caution in patients with liver disease. Dose adjustment of Gavir 250 Capsule may be needed. Please consult your doctor.
If you miss a dose of Gavir 250 Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Natco Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Natco Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)